What question did this study set out to answer?

This study aims to assess the effectiveness and safety of colchicine for treating skin involvement in immunoglobulin A vasculitis.

April 18, 2026Open Access

Colchicine for Skin Involvement in Immunoglobulin A Vasculitis: A Single-Center Case Series and Review of the Literature

Key Points

This study aims to assess the effectiveness and safety of colchicine for treating skin involvement in immunoglobulin A vasculitis.
Reviewed a single-center case series of patients with IgAV
Administered colchicine for persistent or severe skin symptoms
Evaluated outcomes based on patient response to treatment
Colchicine was found to be a safe treatment
Demonstrated effectiveness in managing persistent cutaneous manifestations
Supportive of further controlled studies for validation

Abstract

Colchicine appears to be a safe and effective treatment for persistent, severe, or recurrent cutaneous manifestations of IgAV. These findings support its use in clinical practice and highlight the need for prospective controlled studies.

Colchicine for Skin Involvement in Immunoglobulin A Vasculitis: A Single-Center Case Series and Review of the Literature

Key Points

Abstract

Cite This Study

Also Consider

Also Consider